BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

209 related articles for article (PubMed ID: 329088)

  • 1. [Dopamine in patients with cardiogenic shock (author's transl)].
    Kikis D; Esser H; Trübestein G
    Med Klin; 1977 Jul; 72(28-29):1212-7. PubMed ID: 329088
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [The use of dopamin in shock and heart failure (author's transl)].
    Aroński A; Kübler A; Sliwinski M; Paszkowska A
    Anaesthesist; 1978 Apr; 27(4):183-6. PubMed ID: 655365
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hemodynamic and therapeutic effects of intravenous dopamine.
    Théroux P; Mizgala HF; Bourassa MG
    Can Med Assoc J; 1977 Mar; 116(6):645-8. PubMed ID: 608165
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Hemodynamic study of dopamine used in chronic heart failures and in cardiogenic shock as a complication of acute myocardial infarct].
    Flammang D; Sebastien P; Bouvrain Y
    Ann Anesthesiol Fr; 1975 Dec; 16(9):669-72. PubMed ID: 5028
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Treatment of cardiogenic shock after acute myocardial infarction with intra-aortic balloon counterpulsation (author's transl)].
    Grosser KD; Heller A; Asbeck F; Hübner W; Krüger H; Vogel W; Imig W; Lennartz KJ
    Dtsch Med Wochenschr; 1976 Jun; 101(23):877-82. PubMed ID: 1269428
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Sodium nitroprusside in the treatment of left-sided heart failure in acute myocardial infarction (author's transl)].
    Kupper W; Hanrath P; Bleifeld W; Uebis R; Effert S
    Dtsch Med Wochenschr; 1977 Apr; 102(15):548-54. PubMed ID: 849708
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [First experiences with the use of dopamine (hydroxytyramine) in cardiogenic shock].
    Döring D; Fleischmann HJ; Heunisch K; Köhler H; Trenckmann H
    Z Gesamte Inn Med; 1971 Dec; 26(24):759-63. PubMed ID: 5152441
    [No Abstract]   [Full Text] [Related]  

  • 8. Thrombolytic therapy in cardiogenic shock: effect of increased aortic pressure and rapid tPA administration.
    Garber PJ; Mathieson AL; Ducas J; Patton JN; Geddes JS; Prewitt RM
    Can J Cardiol; 1995 Jan; 11(1):30-6. PubMed ID: 7850662
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Prevention of delayed cardiogenic shock in 850 patients with myocardial infarction (author's transl)].
    Rosival V; Prónay K
    Z Kardiol; 1979 Jan; 68(1):32-5. PubMed ID: 419806
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Differential therapy of cardiogenic shock with dopamine/milrinone in comparison with dopamine/dobutamine].
    Meissner A; Schmelzle T; Simon R
    Z Kardiol; 1996 Nov; 85(11):839-46. PubMed ID: 9064946
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of vasopressin on hemodynamics in patients with refractory cardiogenic shock complicating acute myocardial infarction.
    Jolly S; Newton G; Horlick E; Seidelin PH; Ross HJ; Husain M; Dzavik V
    Am J Cardiol; 2005 Dec; 96(12):1617-20. PubMed ID: 16360345
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Hemodynamics after prindolol and digitalis in acute myocardial infarction (author's transl)].
    Bachour G; Bender F; Hochrein H
    Med Klin; 1976 Mar; 71(10):414-20. PubMed ID: 57564
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacologic support in cardiogenic shock.
    Rude RE
    Adv Shock Res; 1983; 10():35-49. PubMed ID: 6349299
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Concomitant infarction of the right ventricle in patients with acute transmural myocardial infarction (author's transl)].
    Kikis D; Esser H; Stiens R; Bechtelsheimer H
    Med Klin; 1977 Sep; 72(35):1372-8. PubMed ID: 904533
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Pharmacotherapy of cardiogenic shock].
    Ritz R
    Schweiz Med Wochenschr; 1988 Apr; 118(17):626-9. PubMed ID: 2898169
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Correlations among the haemodynamic effects in acute myocardial infarction. Function evaluation and prognosis 12 months later (author's transl)].
    Rossi P; Fornaro GL; Bongo AS; Giordano A; Mazzuero G
    G Ital Cardiol; 1981; 11(8):1055-62. PubMed ID: 7327321
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inotropic therapy for cardiac low output syndrome: comparison of hemodynamic effects of dopamine/dobutamine versus dopamine/dopexamine.
    El Mokhtari NE; Arlt A; Meissner A; Lins M
    Eur J Med Res; 2007 Nov; 12(11):563-7. PubMed ID: 18024265
    [TBL] [Abstract][Full Text] [Related]  

  • 18. ["Cardiac power output" an old tool, possibly a modern tool for assessing cardiac pumping capability, as well as for a short-term prognosis in cardiogenic shock due to acute myocardial infarction].
    Lupi Herrera E; Chuquiure Valenzuela E; González Pacheco H; Cuéllar Velasco BM; Arias Mendoza A; Martínez Sánchez CR
    Arch Cardiol Mex; 2006; 76(1):95-108. PubMed ID: 16749510
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Use of dopamine in the treatment of cardiogenic shock. Preliminary results].
    Chiche P; Baligadoo S
    Ann Anesthesiol Fr; 1975 Dec; 16(9):705-10. PubMed ID: 5034
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hemodynamic effects of sulmazol (ARL-115 BS), a new vasodilator and positive inotropic agent, in patients with cardiogenic shock.
    Simoons ML; Muskens G; Hugenholtz PG
    Herz; 1983 Feb; 8(1):34-40. PubMed ID: 6832691
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.